Uloric (Febuxostat) is a prescription medication created to treat patients suffering from gout. Uloric was first put on the market in the United States in February of 2009.  The drug company that developed and sold Uloric is Takeda Pharmaceuticals. When Uloric was first put on the market, Takeda Pharmaceuticals did not warn doctors, or their patients, that Uloric could cause an increased risk of heart attacks, strokes or other cardiovascular problems, and that it could even cause death.

Our experienced team of medical product liability lawyers is now helping people who suffered a heart attack, stroke or death while taking Uloric medication to treat their gout.  These lawsuits are not against the doctors who prescribed Uloric.  These are product liability lawsuits against Takeda Pharmaceuticals.  The Takeda lawsuits are centered on a “failure to warn” claim because Takeda failed to warn the people taking Uloric of the increased risk of heart attacks and strokes shown to be caused by the medication.

WHAT IS GOUT?

Gout is a form of arthritis materializing as sudden, severe pain, redness, joint tenderness and swelling. Gout is often found in lower joints like the ankles, feet and toes, but it can also appear in the hands, wrists, and fingers.  Gout is caused by elevated uric acid levels in the blood and can be very painful and debilitating.

WHAT IS ULORIC?

Uloric (Febuxostat) is a xanthine oxidase inhibitor prescribed for management of chronic hyperuricemia (increased Uric Acid levels in the blood) in adult patients with gout. Uloric originally was granted FDA approval on February 13, 2009.  When the Food and Drug Administration (FDA) approved Uloric in 2009, the FDA was concerned Uloric could be dangerous and could cause cardiovascular conditions, so it required that Takeda conduct a mandatory post-marketing cardiovascular safety study.

The results of the 6,000-patient safety study trial were published in the New England Journal of Medicine on March 29, 2018. The authors of the study found a statistically significant increased risk of cardiovascular death for users of Uloric compared to users of allopurinol.

WHAT ARE THE ULORIC LAWSUIT DAMAGES?

If you or a loved one experienced a heart attack, stroke, kidney damage or if a loved one died while taking Uloric, then we will be seeking the following damages for you:

• Past and future medical expenses that resulted from the injuries.
• Funeral expenses if you lost a loved one.
• Past and future pain and suffering (physical and mental) caused by the injuries.
• Costs incurred related to the treatment and recovery process.
• Past and future wage loss.
• Past and future loss of earning capacity.
• Past and future loss of the enjoyment of life.
• Punitive damages, if appropriate.

Related Articles

Institutional Sexual Abuse: Holding Organizations Accountable Under New York’s Lookback Law

April 22, 2026

Sexual Abuse in Trusted Institutions: Betrayal of Power  Sexual abuse is a profound violation of trust, especially when it happens within institutions that are meant to protect and...

Read the Article

McKinsey Ruling Is the Latest Chapter in Napoli Shkolnik’s Opioid Fight

April 17, 2026

For years, McKinsey & Company has settled opioid-related claims without ever having to account for its conduct in a courtroom. That is about to change. On March 3,...

Read the Article

Nexgrill & Weber Recall Over 13 Million Grill Brushes: What You Need to Know

April 15, 2026

Between February and March 2026, Nexgrill and Weber issued recalls for more than 13 million metal wire bristle grill brushes after reports that small metal bristles can detach,...

Read the Article